Illinois Cancer Specialists-Niles
Niles, Illinois, United States
Cancer treatment center in Cook County, Illinois
8915 W Golf Rd, Niles, IL 60714
About Illinois Cancer Specialists-Niles
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
44
SWOG Cancer Research Network
16
Eastern Cooperative Oncology Group
15
ECOG-ACRIN Cancer Research Group
13
Celgene
11
Bristol-Myers Squibb
9
US Oncology Research
9
Alliance for Clinical Trials in Oncology
6
Gilead Sciences
4
Pfizer
4
Novartis Pharmaceuticals
3
Clinical Trials at Illinois Cancer Specialists-Niles
During the past decade, Illinois Cancer Specialists-Niles conducted 33 clinical trials. In the 10-year time frame, 33 clinical trials started and 106 clinical trials were completed, i.e. on
average, 321.2% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 41 clinical trials were completed. i.e. 512.5%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
1998-12-01
2025-10-01
Active, not recruiting
1,150
S9921, Hormone Therapy With or Without Mitoxantrone and Prednisone in Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer
1999-10-15
2018-05-01
Completed
983
S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma
2000-08-01
2012-07-01
Completed
432
Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer
2000-10-01
2019-11-01
Completed
1,772
Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Larynx or Oropharynx Cancer
2001-03-01
2009-05-01
Completed
Comparison of Combination Chemotherapy Regimens in Treating Older Women Who Have Undergone Surgery for Breast Cancer
2001-09-01
2012-11-01
Completed
633
Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With AML Leukemia
2002-12-01
2019-12-01
Completed
657
Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer
2002-12-01
2016-12-01
Completed
546
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Illinois Cancer Specialists-Niles" #1 sponsor was "National Cancer Institute (NCI)" with 44 trials, followed by "SWOG Cancer Research Network" with 16 trials
sponsored, "Eastern Cooperative Oncology Group" with 15 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 13 trials sponsored and "Celgene"
with 13 trials sponsored. Other sponsors include 84 different institutions and
companies that sponsored additional 54 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Illinois Cancer Specialists-Niles"
#1 collaborator was "National Cancer Institute (NCI)" with 51 trials as a collaborator, "Cancer and Leukemia Group B" with 9 trials as a collaborator, "NCIC Clinical Trials Group" with 8 trials as a collaborator, "SWOG Cancer Research Network" with 8 trials as a collaborator and "Bristol-Myers Squibb" with 4 trials as a collaborator. Other collaborators include 41 different institutions and companies that were
collaborators in the rest 36 trials.
Clinical Trials Conditions at Illinois Cancer Specialists-Niles
According to Clinical.Site data, the most researched conditions in "Illinois Cancer Specialists-Niles" are
"Breast Cancer" (15 trials), "Multiple Myeloma" (9 trials), "Lymphoma" (8 trials), "Prostate Cancer" (7 trials) and "Colorectal Cancer" (6 trials). Many other conditions were trialed in "Illinois Cancer Specialists-Niles" in a lesser frequency.
Clinical Trials Intervention Types at Illinois Cancer Specialists-Niles
Most popular intervention types in "Illinois Cancer Specialists-Niles" are "Drug" (165 trials), "Biological" (58 trials), "Other" (56 trials), "Procedure" (14 trials) and "Radiation" (12 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (37 trials), "Docetaxel" (18 trials), "Bevacizumab" (16 trials), "Rituximab" (15 trials) and "Cyclophosphamide" (14 trials). Other intervention names were less common.
Clinical Trials Genders at Illinois Cancer Specialists-Niles
The vast majority of trials in "Illinois Cancer Specialists-Niles" are
162 trials for "All" genders, 15 trials for "Female" genders and 10 trials for "Male" genders.
Clinical Trials Status at Illinois Cancer Specialists-Niles
Currently, there are NaN active trials in "Illinois Cancer Specialists-Niles".
undefined are not yet recruiting,
13 are recruiting,
49 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 98 completed trials in Illinois Cancer Specialists-Niles,
undefined suspended trials,
and 22 terminated clinical trials to date.
Out of the total trials that were conducted in Illinois Cancer Specialists-Niles, 11 "Phase 1"
clinical trials were conducted, 85 "Phase 2" clinical
trials and 91 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 5 trials, and there were
also 1 trials that are defined as “Not Applicable".